NLSUI OPAC header image

Public Health, Access to HIV AIDS Medicines and WTO: (Record no. 110308)

MARC details
000 -LEADER
fixed length control field 04471nam a2200229Ia 4500
003 - CONTROL NUMBER IDENTIFIER
control field OSt
005 - DATE AND TIME OF LATEST TRANSACTION
control field 20240330181517.0
008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION
fixed length control field 171016s2003 xx 000 0 und d
040 ## - CATALOGING SOURCE
Transcribing agency NLSIU
100 ## - MAIN ENTRY--PERSONAL NAME
Personal name Lakshimidevi Somnath
245 ## - TITLE STATEMENT
Title Public Health, Access to HIV AIDS Medicines and WTO:
Remainder of title The Doha Declaration and its Aftermath
260 ## - PUBLICATION, DISTRIBUTION, ETC.
Place of publication, distribution, etc. Bangalore
Name of publisher, distributor, etc. NLSIU
Date of publication, distribution, etc. 2003
300 ## - PHYSICAL DESCRIPTION
Extent 161p
505 ## - FORMATTED CONTENTS NOTE
Formatted contents note CONTENTS <br/>TABLE OF CASES;<br/>TABLE STATUTES; <br/>CHAPTER I;<br/>INTRODUCTION; <br/>CHAPTER II; <br/>RESEARCH METHODOLOGY; <br/>2.1. Aims And Objectives; <br/>2.2. Scope And Limitation; <br/>2.3. Method or Analysis; <br/>2.4. Sources of Data; <br/>2.5 - Research Questions; <br/>2.6. Mode or Citation; <br/>CHAPTER III; <br/>WTO AND THE NEW TRADE REGIME: THE TRIPS AGREEMENT; <br/>3.1 - The Nature or Property As Intellectual Property; <br/>3.2 - The Development of the Trips Agreement; <br/>3.3 - Objectives and Principles of TRIPS; <br/>3.4 - Pertinent Provisions of Trips And The Pharmaceutical Industry; <br/>3.5 - The TRIPs Agreement and the Developing Nations; <br/>CHAPTER IV; <br/>THE PHARMACEUTICAL INDUSTRY AND DEVELOPING WORLD; <br/>4.1 - The Global Pharmaceutical Situation; <br/>4.2 - Pharmaceuticals In Developing Countries; <br/>4.3 Medication The Pharmaceutical Industry And Access To Hiv / Aids medication;<br/>CHAPTER V; <br/>ACCESS TO HIV / AIDS DRUGS: A HUMAN RIGHTS PERSPECTIVE; <br/>5.1 - Patent Protection For Pharmaceuticals And International Human Rights;<br/>5.2 - Right To Health Care And Essential Medicines; <br/>5.3 - HIV / AIDS Treatment Access & Human Rights; <br/>5.4 - The Human Right Liability of Pharmaceutical Companies;<br/>5.5 - HIV / AIDS Public Health Crisis as a National Emergency; <br/>CHAPTER VI; <br/>SOUTH AFRICA'S FIGHT FOR HIV / AIDS MEDICATION: AN ANALYSIS; <br/>6.1 - History of HIV / AIDS Drug Availability in South Africa; <br/>6.2 - The South African Response To Limited HIV / AIDS Drug Availability; <br/>6.3 - Analysis of South Africa Medicines and Related Substances Control Amendment Act; <br/>6.4 - Pharmaceutical Corporations v. South Africa: The Quest for Increased Drug Availability; <br/>6.5 - The Final Outcome; <br/>CHAPTER VII; <br/>BATTLING THE AIDS CRISIS: THE EXPERIENCE OF OTHER DEVELOPING COUNTRIES; <br/>7.1 – Brazil; <br/>7.2 – Thailand; <br/>CHAPTER VIII; <br/>INDIA'S HISTORY AND CURRENT STATUS OF HIV/AIDS MEDICATION ;<br/>8.1 - Patent Protection in India from 1970 to 2002; <br/>8.2 - The Pharmaceutical Industry in India;<br/>8.3 - The Indian Pharmaceutical Industry and the Doha Declaration <br/>CHAPTER IX; <br/>THE EVOLUTION OF THE DOHA DECLARATION TRIPS AND PUBLIC HEALTH ;<br/>9.1 - The Content of the Declaration: The Role of Generic Medicines; <br/>9.2 - The Role played by International Institutions; <br/>9.3 - Role Played by Non - Governmental Organizations NGOs; <br/>9.4. Role-played Organization of the Developing Country Group ;<br/>9.5 - Meeting of the TRIPs Council - 20 June 2001; <br/>9.6. Interim Preparations; <br/>9.7. Intervention of Anthrax and Cipro; <br/>9.8 - The Meeting on 27 October 2001; <br/>CHAPTER X; <br/>THE MANDATE OF THE DOHA DECLARATION OF TRIPS AND PUBLIC HEALTH; <br/>10.1 - An Analysis of Doha Declaration; <br/>10.2 - Drug Industry Response to the WTO Declaration on TRIPS and Public Health; <br/>CHAPTER XI; <br/>THE LEGAL ANALYSIS OF THE DOHA DECLARATION ON TRIPS AND PUBLIC HEALTH; <br/>11.1 - The Doha Declaration of Evidence under Subsequent Practice TRIPS;<br/>11.2 - The Doha Declaration as a Legally Non - Binding Statement of Intent and Commitment; <br/>CHAPTER XII; <br/>AFTERMAT TRIPS AND PUBLIC HEALTH ON DECLARATION: THE POST. DOHA AGENDA;<br/>12.1 Issue an Official Interpretation on Public Health; <br/>12.2 Designate WHO's Official Organization to Provide Technical Assistance on TRIPs - Related Health Issues; <br/>12.3 Issue a Formal Interpretative Statement Clarifying TRIPS Article 30 Exceptions; <br/>12.4 Safeguards Against Abuse Must Be Implemented; <br/>12.5 Compile a Database of Generic Products; <br/>12.6 - WTO Ministerial Meeting at Sydney; <br/>12.7 TRIPS Council Meeting in November 2002; <br/>CHAPTER XIII; <br/>CONCLUSION; <br/>BIBLIOGRAPHY; <br/>Articles; <br/>Books; <br/>Agreements;<br/>Constitutions;<br/>Covenant;<br/>Declaration;<br/>Internet references; <br/>Press releases; <br/>Reports <br/>Miscellaneous.<br/><br/>
650 ## - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element HIV / AIDS Medication - India
650 ## - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Pharmaceutical Industry - Developing World
650 ## - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Right to health Card
650 ## - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element WTO- TRIPS- Public Health
700 ## - ADDED ENTRY--PERSONAL NAME
Personal name Prof. V Kesava Rao - Guide
856 ## - ELECTRONIC LOCATION AND ACCESS
Uniform Resource Identifier <a href="http://opac.nls.ac.in:8081/xmlui/handle/123456789/1472">http://opac.nls.ac.in:8081/xmlui/handle/123456789/1472</a>
Link text Content Page
942 ## - ADDED ENTRY ELEMENTS (KOHA)
Source of classification or shelving scheme Dewey Decimal Classification
Koha item type Dissertation
Holdings
Withdrawn status Lost status Damaged status Not for loan Home library Current library Date acquired Total Checkouts Barcode Date last seen Price effective from Koha item type
        National Law School National Law School 22.07.2017   LLM052 28.10.2017 28.10.2017 Dissertation
© 2022 National Law School of India University   
Powered by Koha. Supported by L2C2 Technologies